1.科研項(xiàng)目(主持) (1)山西省優(yōu)青項(xiàng)目(202303021224012):202401-202612,,25萬,,在研 (2)國家自然科學(xué)基金面上項(xiàng)目(82271761):202301-202612,,55萬,,在研 (3)中國博士后基金面上項(xiàng)目(2022M722008):202301-202412,8萬,,在研 (4)國家自然科學(xué)基金青年項(xiàng)目(82001656):202101-202312,24萬,結(jié)題 (5)山西白求恩醫(yī)院科研啟動項(xiàng)目(2021RC009):202107-202506,,20萬,,在研 (6)山西白求恩醫(yī)院國自然“種子選手”培育項(xiàng)目:10萬,在研 (7)山西省博士后項(xiàng)目:202301-202412,,16萬,,在研 2.學(xué)術(shù)論文 (1) SARS-CoV-2 infection causes immunodeficiency in recovered patients by downregulating CD19 expression in B cells via enhancing B-cell metabolism, Signal Transduction and Targeted Therapy,2021(共一第一,IF=38.1, TOP1區(qū)) (2) STING couples with PI3K to regulate actin reorganization during BCR activation, Science Advances, 2020(共一第一,,IF=13.1, TOP1區(qū)) (3) Dedicator of cytokinesis protein 2 couples with lymphoid enhancer-binding factor 1 to regulate expression of CD21 and B-cell differentiation, Journal of Allergy and Clinical Immunology, 2019(共一第一,,IF=14.1, TOP1區(qū)) (4) DOCK2 couples with LEF-1 to regulate B cell metabolism and memory response, Biochemical and Biophysical Research Communications, 2020(共一第二,IF=2.7) (5)A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection,Applied microbiology and biotechnology; 2015(共一第三,,IF=3.6) (6) Expression of USP25 associates with fibrosis, inflammation and metabolism changes in IgG4-related disease, Nature Communication; 2024(第二作者,,IF=16.6) 3. 學(xué)術(shù)任職:山西省檢驗(yàn)醫(yī)師學(xué)會青年委員會副主任委員 |